Insmed Incorporated
Clinical trials sponsored by Insmed Incorporated, explained in plain language.
-
Inhaled drug tested for long-term safety in lung-related high blood pressure
Disease control Not yet recruitingThis phase 3 study tests the long-term safety of an inhaled drug called treprostinil palmitil for people with pulmonary hypertension caused by interstitial lung disease. About 344 adults who completed an earlier trial will take the drug for up to 2 years. Researchers will track s…
Phase: PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Liver health may change how body handles inhaled lung drug
Knowledge-focused Not yet recruitingThis phase 1 trial investigates how mild, moderate, and severe liver impairment affects the way the body processes a single inhaled dose of treprostinil palmitil, a drug used for certain lung conditions. The study enrolls about 30 adults with varying levels of liver function and …
Phase: PHASE1 • Sponsor: Insmed Incorporated • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC